Grapefruit juice improves glucose intolerance in streptozotocin-induced diabetes by suppressing hepatic gluconeogenesis
- 461 Downloads
Hypoglycemic effects of grapefruit juice (GFJ) are widely recognized, but the mechanism(s) by which GFJ lowers blood glucose levels have not previously been investigated.
Wistar rats [250–300 g body weight (BW)] were divided into eight groups (n = 7). Group 1 animals were orally treated with 3.0 ml/kg BW of distilled water for 60 days, while groups 3, 4, 5, 6 were similarly treated with 3.0 ml/kg BW of GFJ. Groups 4 and 7 as well as 2, 5, 6 and 8 were given 45.0 and 60.0 mg/kg BW intraperitoneal injections streptozotocin, respectively, while groups 2 and 6 animals were additionally injected with insulin (4.0 units/kg, S.C., b.d), respectively. Fasting blood glucose (FBG) and glucose tolerance tests were done. Hepatic glycogen content and glucokinase, glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK) activities were measured in homogenized liver tissues.
Diabetic rats, groups 2 and 4–8 exhibited significantly reduced weight gain but increased polydipsia compared to controls. FBG was significantly increased in diabetic rats compared to controls but were significantly improved in GFJ-treated—compared to non-treated—diabetic rats. Similarly, diabetic rats showed significant glucose intolerance compared to controls which was improved by GFJ treatment. GFJ treatment did not improve fasting plasma insulin in diabetic rats. GFJ treatment significantly elevated glucokinase activity and hepatic glycogen concentrations but suppressed the activities of G6Pase and PEPCK, respectively, in diabetic animals.
These findings show that GFJ is not insulinotropic but improves glucose intolerance in diabetic rats by suppressing hepatic gluconeogenesis.
KeywordsGrapefruit juice Diabetes Insulin Gluconeogenesis
The study was supported by a grant from the Medical Research Council of South African, and there is no conflict of interest to declare. The authors also wish to thank the Biomedical Resource Unit of the University of KwaZulu-Natal for helping with in vivo animal work as well as the final year BPharm students; Dludlu S, Govender K, Mahomed R, Moola W, Ngcobo L, Prem R, Ramasir S for helping with experimental work.
Conflict of interest
None to declare.
- 1.Florida department of citrus: history of dieting, Florida, Department of Citrus, Lakeland FL, 2003Google Scholar
- 2.Bailey DG, Spence JD, Edgar B, Bayliff CD, Arnold JM (1989) Ethanol enhances the hemodynamic effects of felodipine. Clin Invest Med 12:357–362Google Scholar
- 8.Gorinstein S, Leontowiwicz TH, Leontowicz M et al (2005) Red Star Ruby (Sunrise) and blood quantities of Jaffa grapefruits and their influence on plasma lipid levels and plasma antioxidant activity in rats fed with cholesterol-containing and cholesterol-free diets. Life Sci 77:2384–2397CrossRefGoogle Scholar
- 11.Owira PMO, Ojewole JAO (2009) Grapefruit juice improves glycemic control but also exacerbates metformin-induced lactic acidosis in non-diabetic rats. Methods Find Exp Clin Pharmacol 31:563–570Google Scholar
- 12.Seifter S, Dayton S et al (1950) The estimation of glycogen with anthrone reagent. Arch Biochem Biophys 25:191–200Google Scholar
- 14.Barzila N, Roseseti L (1993) Role of glucokinase and glucose-6-phosphate in the acute and chronic regulation of hepatic glucose fluxes by insulin. J Biol Chem 268:25019–25025Google Scholar
- 16.Lange AJ, Arion WJ, Burchell A et al (1986) Aluminum ions are required for stabilization and inhibition of hepatic microsomal glucose-6-phosphatase by sodium fluoride. J Biol Chem 261:101–107Google Scholar
- 17.Bentle LA, Lardy HA (1976) Interaction of anions and divalent metal ions with phosphoenolpyruvate carboxykinase. J Biol Chem 251:2916–2921Google Scholar
- 21.Herling AW, Burger HJ, Schwab D et al (1998) Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system. Am J Physiol 274:G1087–G1093Google Scholar
- 25.Jung UJ, Lee MK, Jeong KS et al (2004) Hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J Nutr 134:2499–2503Google Scholar